Skip to main content
HHS Logo U.S. Department of Health & Human Services NIH logo National Institutes of Health

Preclinical Innovation

NCATS Researchers Develop New BABM Approach to Assess a Drug Compound’s Activity

NCATS researchers, led by Ruili Huang, Ph.D., and Wei Zheng, Ph.D., develop an approach called biological activity-based modeling (BABM), which could speed the search for therapies for COVID-19 and other diseases.

Lung cancer cells
NCATS’ Matrix Screening Platform Helps Researchers Discover Drug Combination to Treat SCLC

Researchers from NCATS and the National Cancer Institute teamed up to identify and test different drug combinations against small cell lung cancer (SCLC).

Improving the Drug Development Process

Creating and testing innovative methods to improve and accelerate the drug development process and find new treatments for patients faster.

Repurposing Drugs

Discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside.

Testing & Predictive Models

Developing better model systems for drug and toxicity testing.

Core Technologies

Using state-of-the-art resources to enable the ongoing operation of all NCATS translational research activities.

Improving the Drug Development Process

Creating and testing innovative methods to improve and accelerate the drug development process and find new treatments for patients faster.

Repurposing Drugs

Discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside.

Testing & Predictive Models

Developing better model systems for drug and toxicity testing.

Core Technologies

Using state-of-the-art resources to enable the ongoing operation of all NCATS translational research activities.